State Street
OMGA

State Street’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

State Street’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-94,730
Closed -$70.6K – 4329
2024
Q4 		$70.6K Hold
94,730
– – ﹤0.01% 4063
2024
Q3 		$116K Hold
94,730
– – ﹤0.01% 3953
2024
Q2 		$196K Sell
94,730
-386,847
-80% -$912K ﹤0.01% 3832
2024
Q1 		$1.76M Buy
481,577
+30,144
+7% +$116K ﹤0.01% 3322
2023
Q4 		$1.36M Buy
451,433
+16,300
+4% +$33K ﹤0.01% 3413
2023
Q3 		$936K Buy
435,133
+46,000
+12% +$184K ﹤0.01% 3547
2023
Q2 		$2.18M Buy
389,133
+333,403
+598% +$2.61M ﹤0.01% 3373
2023
Q1 		$336K Buy
55,730
+4,200
+8% +$29.2K ﹤0.01% 3886
2022
Q4 		$294K Buy
51,530
+11,800
+30% +$66.2K ﹤0.01% 3952
2022
Q3 		$215K Buy
39,730
+8,100
+26% +$41K ﹤0.01% 4114
2022
Q2 		$120K Sell
31,630
-183,138
-85% -$682K ﹤0.01% 4442
2022
Q1 		$1.34M Buy
214,768
+109,900
+105% +$1.12M ﹤0.01% 3717
2021
Q4 		$1.19M Buy
104,868
+35,541
+51% +$676K ﹤0.01% 3775
2021
Q3 		$1.31M Buy
+69,327
New +$1.33M ﹤0.01% 3728

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

State Street's OMGA Position: Q1 2025 in Review

State Street sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 94,730 shares — an estimated $70.6K sold.

State Street first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $2.18M in Q2 2023. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • State Street reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • State Street sold 94,730 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $70.6K.
  • State Street first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • State Street's Omega Therapeutics, Inc. Common Stock position peaked at $2.18M in Q2 2023.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on State Street's 13F filing for Q1 2025, filed 15 May 2025.